• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低长链非编码RNA通过靶向轴抑制顺铂耐药性、细胞增殖、迁移及侵袭顺铂耐药性非小细胞肺癌细胞。

Knockdown of Long Non-Coding RNA Suppresses Cisplatin Resistance, Cell Proliferation, Migration and Invasion of DDP-Resistant NSCLC Cells by Targeting Axis.

作者信息

Zhan Yiyi, Abuduwaili Kahaerjiang, Wang Xiuli, Shen Yanli, Nuerlan Saiteer, Liu Chunling

机构信息

The Second Department of Pulmonary Medicine, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Aug 24;12:7725-7737. doi: 10.2147/CMAR.S246299. eCollection 2020.

DOI:10.2147/CMAR.S246299
PMID:32943921
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7455504/
Abstract

BACKGROUND

Long non-coding RNA (lncRNA) has been reported to be associated with cisplatin (DDP) resistance in different human cancers including non-small cell lung cancer (NSCLC). However, the mechanism of HOTAIR in cisplatin resistance of NSCLC remains largely undefined.

MATERIALS AND METHODS

Expression of , and () was detected using real-time quantitative PCR (RT-qPCR) and Western blotting. Cisplatin resistance was determined with cell counting kit (CCK)-8 assay and transwell assays in vitro, and xenograft tumor models in vivo. The target binding between and either or was predicted on Diana Tools website, and confirmed by dual-luciferase reporter assay and RNA immunoprecipitation.

RESULTS

Expression of was upregulated in DDP-resistant NSCLC tumor tissues and cell lines (A549/DDP and H1299/DDP). Knockdown of decreased the acquired cisplatin resistance of A549/DDP and H1299/DDP cells, as evidenced by attenuated 50% inhibitory concentration (IC50) of DDP, cell proliferation, migration and invasion in vitro, as well as tumor growth inhibition in vivo. Mechanically, negatively regulated expression via targeting, and DCLK1 was a downstream target for miR-149-5p. was indirectly regulated by in DDP-resistant NSCLC cells as well. Functionally, deletion could counteract the inhibitory effect of HOTAIR knockdown on cisplatin resistance; contrarily, restoring exhibited the similar inhibition on cisplatin resistance in DDP-resistant cells in vitro, which was then abated by upregulation.

CONCLUSION

Knockdown of enhances DDP-resistant NSCLC cells to overcome cisplatin resistance partially via regulating / axis.

摘要

背景

长链非编码RNA(lncRNA)已被报道与包括非小细胞肺癌(NSCLC)在内的不同人类癌症中的顺铂(DDP)耐药性相关。然而,HOTAIR在NSCLC顺铂耐药中的机制仍不清楚。

材料与方法

采用实时定量PCR(RT-qPCR)和蛋白质免疫印迹法检测 、 和 ()的表达。用细胞计数试剂盒(CCK)-8法和体外Transwell实验以及体内异种移植瘤模型测定顺铂耐药性。在Diana Tools网站上预测 与 或 之间的靶标结合,并通过双荧光素酶报告基因实验和RNA免疫沉淀法进行验证。

结果

在DDP耐药的NSCLC肿瘤组织和细胞系(A549/DDP和H1299/DDP)中表达上调。敲低 可降低A549/DDP和H1299/DDP细胞获得性顺铂耐药性,表现为DDP的50%抑制浓度(IC50)降低、体外细胞增殖、迁移和侵袭减弱以及体内肿瘤生长抑制。机制上, 通过靶向负调控 表达,且DCLK1是miR-149-5p的下游靶标。在DDP耐药的NSCLC细胞中, 也间接受 调控。功能上, 缺失可抵消HOTAIR敲低对顺铂耐药性的抑制作用;相反,恢复 在体外对DDP耐药细胞的顺铂耐药性表现出类似的抑制作用,而这种作用随后被 上调所减弱。

结论

敲低 通过调节 / 轴部分增强DDP耐药的NSCLC细胞克服顺铂耐药性的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/91f6a0c63e8d/CMAR-12-7725-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/f7feca26c0aa/CMAR-12-7725-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/50b738ec2c07/CMAR-12-7725-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/a83724efb565/CMAR-12-7725-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/d403ff5ba508/CMAR-12-7725-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/9db4367caa33/CMAR-12-7725-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/58afd26af562/CMAR-12-7725-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/91f6a0c63e8d/CMAR-12-7725-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/f7feca26c0aa/CMAR-12-7725-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/50b738ec2c07/CMAR-12-7725-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/a83724efb565/CMAR-12-7725-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/d403ff5ba508/CMAR-12-7725-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/9db4367caa33/CMAR-12-7725-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/58afd26af562/CMAR-12-7725-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fff/7455504/91f6a0c63e8d/CMAR-12-7725-g0007.jpg

相似文献

1
Knockdown of Long Non-Coding RNA Suppresses Cisplatin Resistance, Cell Proliferation, Migration and Invasion of DDP-Resistant NSCLC Cells by Targeting Axis.敲低长链非编码RNA通过靶向轴抑制顺铂耐药性、细胞增殖、迁移及侵袭顺铂耐药性非小细胞肺癌细胞。
Cancer Manag Res. 2020 Aug 24;12:7725-7737. doi: 10.2147/CMAR.S246299. eCollection 2020.
2
LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.长链非编码 RNA SNHG1 通过 miR-330-5p/DCLK1 轴促进 NSCLC 的顺铂耐药和进展。
Exp Mol Pathol. 2021 Jun;120:104633. doi: 10.1016/j.yexmp.2021.104633. Epub 2021 Mar 19.
3
miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).miR-186-5p 通过靶向 SIX1 抑制非小细胞肺癌细胞(NSCLCs)对顺铂的耐药性。
Neoplasma. 2020 Jan;67(1):147-157. doi: 10.4149/neo_2019_190511N420. Epub 2019 Nov 4.
4
Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.外泌体传递的 circVMP1 通过靶向 miR-524-5p-METTL3/SOX2 轴促进非小细胞肺癌的进展和顺铂耐药性。
Drug Deliv. 2022 Dec;29(1):1257-1271. doi: 10.1080/10717544.2022.2057617.
5
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.长链非编码 RNA HOTAIR 的敲低通过抑制 miR-138-5p 调控的 EZH2 和 SIRT1 逆转卵巢癌细胞对顺铂的耐药性。
Biol Res. 2020 Apr 29;53(1):18. doi: 10.1186/s40659-020-00286-3.
6
Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.长链非编码 RNA SNHG1 通过调节 miR-140-5p/Wnt/β-catenin 通路促进非小细胞肺癌对顺铂的耐药性。
Neoplasma. 2019 Sep;66(5):756-765. doi: 10.4149/neo_2018_181218N980. Epub 2019 Jun 18.
7
HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis.HOTAIR 通过 miR-106a-5p/STAT3 轴调节骨肉瘤细胞增殖、侵袭和凋亡促进顺铂耐药。
Cell Transplant. 2020 Jan-Dec;29:963689720948447. doi: 10.1177/0963689720948447.
8
Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.环状 RNA PRMT5 敲低通过调节 miR-138-5p/MYH9 轴增强非小细胞肺癌对顺铂的敏感性和免疫反应。
J BUON. 2021 Sep-Oct;26(5):1850-1861.
9
Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.环状 RNA PIP5K1A 通过依赖于 miR-493-5p/ROCK1 轴调控非小细胞肺癌细胞及异种移植鼠模型中的顺铂耐药和恶性进展。
Respir Res. 2021 Sep 18;22(1):248. doi: 10.1186/s12931-021-01840-7.
10
Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.Hsa_circ_0017639 通过作为 miR-1296-5p 的分子海绵并调节 sine oculis homeobox 1 表达来调节顺铂耐药性和肿瘤生长,在非小细胞肺癌中。
Bioengineered. 2022 Apr;13(4):8806-8822. doi: 10.1080/21655979.2022.2053810.

引用本文的文献

1
Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer.非小细胞肺癌中长链非编码RNA介导的治疗耐药性综述
Cancer Cell Int. 2024 Nov 9;24(1):369. doi: 10.1186/s12935-024-03549-1.
2
E74-like ETS transcription factor 1 promotes the progression of pancreatic cancer by regulating doublecortin-like kinase 1/Janus kinase/signal transducer and activator of transcription pathway.E74样ETS转录因子1通过调控双皮质素样激酶1/Janus激酶/信号转导及转录激活因子途径促进胰腺癌进展。
Am J Cancer Res. 2024 Feb 15;14(2):616-629. doi: 10.62347/TEWF1767. eCollection 2024.
3
Interaction between long noncoding RNA and microRNA in lung inflammatory diseases.

本文引用的文献

1
DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.DCLK1 可诱导结直肠癌中 TRIB3、EMT、耐药性和不良预后。
Carcinogenesis. 2020 May 14;41(3):303-312. doi: 10.1093/carcin/bgz157.
2
Emerging role of HOX genes and their related long noncoding RNAs in lung cancer.HOX 基因及其相关长非编码 RNA 在肺癌中的新兴作用。
Crit Rev Oncol Hematol. 2019 Jul;139:1-6. doi: 10.1016/j.critrevonc.2019.04.019. Epub 2019 Apr 27.
3
Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway.
长链非编码 RNA 与肺部炎症性疾病中 microRNA 的相互作用。
Immun Inflamm Dis. 2024 Jan;12(1):e1129. doi: 10.1002/iid3.1129.
4
Targeting PAK4 reverses cisplatin resistance in NSCLC by modulating ER stress.靶向PAK4通过调节内质网应激逆转非小细胞肺癌中的顺铂耐药性。
Cell Death Discov. 2024 Jan 18;10(1):36. doi: 10.1038/s41420-024-01798-7.
5
LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.LINC00460 通过靶向 miR-149-5p/DLL1 轴并激活 Notch 通路,在体内外促进神经母细胞瘤肿瘤发生和顺铂耐药。
Drug Deliv Transl Res. 2024 Jul;14(7):2003-2018. doi: 10.1007/s13346-023-01505-6. Epub 2023 Dec 31.
6
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers.miR-149-5p 在人类癌症中的抑瘤和致癌作用。
Int J Mol Sci. 2022 Sep 16;23(18):10823. doi: 10.3390/ijms231810823.
7
Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A systematic review and meta-analysis.长链非编码RNA HOTAIR多态性与肺癌风险的关联:一项系统评价和荟萃分析。
Exp Ther Med. 2022 Jun 29;24(2):540. doi: 10.3892/etm.2022.11477. eCollection 2022 Aug.
8
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review.微小RNA在五大最致命癌症对顺铂化疗耐药中的作用:最新综述
Front Pharmacol. 2022 Apr 4;13:831099. doi: 10.3389/fphar.2022.831099. eCollection 2022.
9
A Review on the Role of miR-149-5p in the Carcinogenesis.miR-149-5p 在癌症发生中的作用研究进展
Int J Mol Sci. 2021 Dec 30;23(1):415. doi: 10.3390/ijms23010415.
10
Influence of LncRNA SDHAP1 on multiplication, migration and invasiveness of non-small cell lung carcinoma cells.长链非编码RNA SDHAP1对非小细胞肺癌细胞增殖、迁移和侵袭能力的影响
Am J Transl Res. 2021 Oct 15;13(10):11245-11254. eCollection 2021.
长链非编码 RNA HOTAIR 通过 miR-217/DACH1 信号通路调控非小细胞肺癌的发生发展。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):670-678. doi: 10.26355/eurrev_201901_16905.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1.撤回:miR-539 通过靶向 DCLK1 增强非小细胞肺癌对顺铂的化疗敏感性。
Biomed Pharmacother. 2018 Oct;106:1072-1081. doi: 10.1016/j.biopha.2018.07.024. Epub 2018 Jul 17.
6
Emerging role of long non-coding RNAs in cisplatin resistance.长链非编码RNA在顺铂耐药中的新作用。
Onco Targets Ther. 2018 May 28;11:3185-3194. doi: 10.2147/OTT.S158104. eCollection 2018.
7
The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway.lncRNA-HOTAIR通过调控Wnt信号通路对非小细胞肺癌耐药性的作用机制。
Exp Ther Med. 2018 Jun;15(6):4885-4889. doi: 10.3892/etm.2018.6052. Epub 2018 Apr 11.
8
MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.微小RNA-149通过靶向X连锁凋亡抑制蛋白抑制卵巢癌细胞的增殖并增强其对顺铂的敏感性。
Oncol Lett. 2018 May;15(5):7328-7334. doi: 10.3892/ol.2018.8240. Epub 2018 Mar 12.
9
MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β.微小RNA-149通过靶向DNA聚合酶β使食管癌细胞系对顺铂敏感。
J Cell Mol Med. 2018 Aug;22(8):3857-3865. doi: 10.1111/jcmm.13659. Epub 2018 May 4.
10
Silencing of LncRNA-HOTAIR decreases drug resistance of Non-Small Cell Lung Cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1.长链非编码RNA-HOTAIR的沉默通过抑制ULK1的磷酸化使自噬失活,从而降低非小细胞肺癌细胞的耐药性。
Biochem Biophys Res Commun. 2018 Mar 18;497(4):1003-1010. doi: 10.1016/j.bbrc.2018.02.141. Epub 2018 Feb 19.